Ovation Science Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Terry H. Howlett
- Full Time Employees
- 5
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 625 Howe street Vancouver BC Canada V6C 2T6
- IPO Date
- Jan 29, 2019
- Website
- ovationscience.com
- Similar Companies
- Business
- Ovation Science Inc is a research and development company specializing in the development and licensing of proprietary topical and transdermal cannabis and hemp-based products. The company’s core offerings include patented delivery technology known as Invisicare®, which facilitates enhanced skin absorption of cannabinoids such as CBD, CBN, CBG, and THC. Ovation Science’s product portfolio comprises health and wellness formulations branded under Invibe® MD, which feature hemp-derived CBD, and ARLO CBD Beauty, a line focused on anti-aging skincare solutions enriched with CBD. These products are developed using pharmaceutical drug development protocols and are licensed to national and international companies that manufacture and market them globally. The company operates primarily in Canada and the United States. Founded with a focus on innovation, Ovation Science does not manufacture or distribute finished cannabis products directly but licenses its patented polymer technology and product formulations to partner companies who produce and market products using this technology. The company generates revenue through multiple streams including development fees, licensing fees, royalties, and the sale of Invisicare polymer to its licensees. In the last two years, Ovation Science has entered into several strategic developments including an enhanced partnership with Skinvisible Pharmaceuticals to expand cannabinoid delivery technology into the obesity and metabolic health markets with new patent protections. The company also executed exclusive licensing agreements for its topical and transdermal formulations in key markets such as Missouri and Florida, including a major partnership with MidWest Roots, LLC in Missouri and expansion with Planet 13 in Florida’s dispensary network. Additionally, Ovation completed a non-brokered private placement financing in 2025 to raise funds for business operations and growth. The company’s headquarters are located in Vancouver, British Columbia, and it has a wholly-owned subsidiary, Ovation Science USA Inc., supporting its U.S. operations. Ovation Science Inc represents a unique blend of pharmaceutical drug development expertise and cannabis industry-focused technology innovation, positioning itself as a leader in cannabinoid topical and transdermal delivery systems tailored for health, wellness, and beauty markets across North America.
Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products
Ovation Science Sees Expanded Opportunities for Its Topical Products Following U.S. Cannabis Rescheduling
Ovation Science and Skinvisible Pharmaceuticals Enhance Their Strategic Partnership in the Obesity Market with Innovative Cannabinoid Delivery Technology with New Developments and Patent Protection
Ovation Science Expands with Planet 13 into Florida
Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania
Ovation Science Topicals Launch with Planet 13 in Nevada
Planet 13 Launches New MEDIZIN Branded Topicals - Introducing MEDIZIN Rest, Recovery and Relief
Ovation Science Expands Market Reach with Exclusive Canadian License Agreement
Ovation Science Announces License Agreement for Its Topical / Transdermal Cannabis Products for Missouri
Ovation Science Signs License Agreement with Planet 13 for Its Topical / Transdermal Cannabis Products for Nevada